1. Home
  2. CDE vs FMS Comparison

CDE vs FMS Comparison

Compare CDE & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeur Mining Inc.

CDE

Coeur Mining Inc.

HOLD

Current Price

$16.24

Market Cap

13.5B

ML Signal

HOLD

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$22.39

Market Cap

14.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDE
FMS
Founded
1928
1996
Country
United States
Germany
Employees
N/A
N/A
Industry
Precious Metals
Misc Health and Biotechnology Services
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
14.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CDE
FMS
Price
$16.24
$22.39
Analyst Decision
Strong Buy
Sell
Analyst Count
5
2
Target Price
$22.40
$30.00
AVG Volume (30 Days)
23.1M
505.5K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
2.56%
EPS Growth
533.33
N/A
EPS
0.95
N/A
Revenue
$709,598,000.00
N/A
Revenue This Year
$86.56
$1.41
Revenue Next Year
$55.52
$4.11
P/E Ratio
$18.71
$15.62
Revenue Growth
N/A
N/A
52 Week Low
$4.58
$20.96
52 Week High
$27.77
$30.46

Technical Indicators

Market Signals
Indicator
CDE
FMS
Relative Strength Index (RSI) 28.78 44.60
Support Level $15.24 $20.96
Resistance Level $17.88 $24.08
Average True Range (ATR) 1.18 0.34
MACD -0.57 -0.06
Stochastic Oscillator 0.63 42.56

Price Performance

Historical Comparison
CDE
FMS

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico generating maximum revenue from United States.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: